Clinical role of 11C-methionine PET/CT in renal cell carcinoma
- Conditions
- Neoplasms
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
1) Patients with clinically suspected primary kidney cancer (renal cell carcinoma)
2) Patients undergoing diagnostic tests for staging after being confirmed as primary kidney cancer
3) Patients planning nephrectomy due to suspected kidney cancer
4) The age allowed to participate in the study is adults between 20 and 90 years old.
1) Patients suspected of having metastatic cancer other than primary renal cancer or diagnosed with metastatic cancer
2) Patients diagnosed with benign tumors other than primary kidney cancer
3) Pregnant patients, nursing mothers
4) children
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor Stage Prediction
- Secondary Outcome Measures
Name Time Method Overall survival and Progression free survival